This inventor holds 1 USPTO granted patent. Top assignee: Biotropics Malaysia Berhad. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Noorsyarida Mohd Sapiai: Innovator in Inflammatory Disease Treatment
Introduction
Noorsyarida Mohd Sapiai is a notable inventor based in Ipoh, Malaysia. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for inflammatory diseases. His innovative work has led to the creation of a patent that addresses critical health issues.
Latest Patents
Noorsyarida holds a patent for "Clerodane derivatives for modulation of leukotriene receptor activity and related diseases." This patent focuses on the use of extracts containing special clerodane compounds to combat inflammatory and allergic diseases. The patent outlines methods for using these compounds in pharmaceutical formulations aimed at therapeutic and prophylactic treatments. His work emphasizes the importance of natural compounds in developing effective medications for various inflammatory conditions.
Career Highlights
Noorsyarida is associated with Biotropics Malaysia Berhad, a company dedicated to the research and development of natural health products. His role in the company has allowed him to explore innovative solutions for health challenges, particularly those related to inflammation. His expertise in this area has positioned him as a key figure in the field of medicinal research.
Collaborations
Noorsyarida has collaborated with esteemed colleagues such as Ernst Roemer and Matthias Gehling. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.
Conclusion
Noorsyarida Mohd Sapiai's contributions to the field of medicinal chemistry are noteworthy. His patent on clerodane derivatives showcases his commitment to addressing inflammatory diseases through innovative research. His work continues to inspire advancements in the treatment of health conditions that affect many individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile